Literature DB >> 467279

Lipid lowering drugs: what is their place in therapeutics?

L Simons.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 467279     DOI： 10.2165/00003495-197917060-00006

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  7 in total

1.  Clofibrate and niacin in coronary heart disease.

Authors: 
Journal:  JAMA       Date:  1975-01-27       Impact factor: 56.272

2.  A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators.

Authors: 
Journal:  Br Heart J       Date:  1978-10

3.  Colestipol hydrochloride in hypercholesterolemic patients--effect on serum cholesterol and mortality.

Authors:  A E Dorr; K Gundersen; J C Schneider; T W Spencer; W B Martin
Journal:  J Chronic Dis       Date:  1978-01

4.  Clofibrate in coronary heart disease. Effect on morbidity and mortality.

Authors:  L R Krasno; G J Kidera
Journal:  JAMA       Date:  1972-02-14       Impact factor: 56.272

5.  Reduction of myocardial reinfarction by the combined treatment with clofibrate and nicotinic acid.

Authors:  L A Carlson; M Danielson; I Ekberg; B Klintemar; G Rosenhamer
Journal:  Atherosclerosis       Date:  1977-09       Impact factor: 5.162

6.  Ischaemic heart disease: a secondary prevention trial using clofibrate. Report by a research committee of the Scottish Society of Physicians.

Authors: 
Journal:  Br Med J       Date:  1971-12-25

7.  Trial of clofibrate in the treatment of ischaemic heart disease. Five-year study by a group of physicians of the Newcastle upon Tyne region.

Authors: 
Journal:  Br Med J       Date:  1971-12-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.